Endast för hälso-och sjukvårdspersonal
Optimizing CAR-T Bridging Therapy in LBCL
Duration: 55 minutes
Listen in to Prof Thorsten Zenz, University Hospital Zürich in Switzerland, providing clinical experiences on timing and bridging therapies before CAR T-cell infusion in aggressive B-cell lymphoma, to gain new insights on how to optimize efficacy and safety of CAR-T in everyday practice.
Related videos
Biomarkers in LBCL
Post-CAR-T treatment and outpatient setting
News
Learn about current topics in hematology, such as new research data, news from events, congresses and more.
Education
Find past and upcoming educational events and access learning tools such as webinars, training videos and expert interviews.
HE-NOR-2500031 10 DEC 2025 video/ 2009-SE-2500035 01/2026